Standout Papers

IL-17-producing γδ T cells and neutrophil... 2001 2026 2009 2017 1.3k
  1. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis (2015)
    Seth B. Coffelt, Kelly Kersten et al. Nature
  2. Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research (2014)
    Manuel Hidalgo, Frédéric Amant et al. Cancer Discovery
  3. Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer (2001)
    Jos Jonkers, Ralph Meuwissen et al. Nature Genetics
  4. High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs (2008)
    Sven Rottenberg, Janneke E. Jaspers et al. Proceedings of the National Academy of Sciences
  5. Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways (2014)
    Mirjam C. Boelens, Tony J. Wu et al. Cell
  6. Induction of medulloblastomas inp53-null mutant mice by somatic inactivation ofRbin the external granular layer cells of the cerebellum (2000)
    Silvia Marino, Marc Vooijs et al. Genes & Development
  7. The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance (2012)
    Peter Bouwman, Jos Jonkers Nature reviews. Cancer
  8. PARP Inhibitor Efficacy Depends on CD8+ T-cell Recruitment via Intratumoral STING Pathway Activation in BRCA-Deficient Models of Triple-Negative Breast Cancer (2019)
    Constantia Pantelidou, Olmo Sonzogni et al. Cancer Discovery
  9. Loss of p53 triggers WNT-dependent systemic inflammation to drive breast cancer metastasis (2019)
    Max D. Wellenstein, Seth B. Coffelt et al. Nature
  10. Understanding and overcoming resistance to PARP inhibitors in cancer therapy (2021)
    Mariana Paes Dias, Sarah C. Moser et al. Nature Reviews Clinical Oncology
  11. ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer (2020)
    Rowan Miller, Alexandra Léary et al. Annals of Oncology
  12. Replication gaps are a key determinant of PARP inhibitor synthetic lethality with BRCA deficiency (2021)
    Ke Cong, Min Peng et al. Molecular Cell

Immediate Impact

2 by Nobel laureates 35 from Science/Nature 82 standout
Sub-graph 1 of 20

Citing Papers

SOX17 enables immune evasion of early colorectal adenomas and cancers
2024 StandoutNature
Pan-cancer whole-genome comparison of primary and metastatic solid tumours
2023 StandoutNature
18 intermediate papers

Works of Jos Jonkers being referenced

The Tandem Duplicator Phenotype Is a Prevalent Genome-Wide Cancer Configuration Driven by Distinct Gene Mutations
2018
Chromosome instability induced by Mps1 and p53 mutation generates aggressive lymphomas exhibiting aneuploidy-induced stress
2014
and 9 more

Author Peers

Author Last Decade Papers Cites
Jos Jonkers 13413 10011 3189 4045 235 20.9k
Robert D. Cardiff 14681 10620 3674 4725 332 25.0k
Geoffrey J. Lindeman 10196 10732 2554 4622 189 17.7k
Jeffrey M. Rosen 14472 10047 4939 4861 292 24.0k
Jane E. Visvader 14304 13013 2730 5804 181 24.5k
William J. Muller 13130 9110 2677 3765 264 20.9k
Dennis C. Sgroi 10910 8548 2552 6671 172 20.7k
Lynda Chin 20167 9178 2593 6652 159 29.0k
Andrew L. Kung 16386 6498 1378 4559 282 23.8k
Ruggero De Maria 12929 8925 1350 6023 256 22.5k
Giorgio Stassi 8994 8848 1366 4245 174 17.6k

All Works

Loading papers...

Rankless by CCL
2026